Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

Employees

Sector

Drug Retailers

More about the company

Quotes

Date	Price	Change	Volume
26-10-01	US$0.8102	-1.81%	6,693
26-09-30	US$0.8251	+3.14%	73,906
26-09-29	US$0.8000	-0.76%	83,193
26-09-28	US$0.8061	-2.88%	183,421
26-09-25	US$0.8300	-8.35%	9,017,692

Delayed Quote Nasdaq

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Delayed Nasdaq 11:48:44 2026-10-01 EDT			5-day change	1st Jan Change
0.8102 ^USD	-1.81%		-10.53%	-99.81%

07-31	Ridgetech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
07-21	Top Premarket Gainers	MT

Market Cap	2.99M 2.64M 2.5M 2.26M 4.25M 287M 4.31M 29.89M 11.5M 147M 11.25M 11M 471M	P/E 2025	0.57x	P/E 2026	-0.28x
Enterprise Value	-14.89M -13.11M -12.42M -11.21M -21.14M -1.43B -21.41M -149M -57.19M -730M -55.9M -54.68M -2.34B	EV / Sales 2025	0.03x	EV / Sales 2026	-0.13x
Free-Float	99.59%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
Nasdaq	RDGT	Delayed
CBOE	RDGT	Real-time

07-31	Ridgetech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
07-21	Top Premarket Gainers	MT
06-23	Top Premarket Gainers	MT
03-05	Ridgetech, Inc. Reports Earnings Results for the Half Year Ended September 30, 2025	CI
03-04	Ridgetech unveils 2026 dual-engine growth strategy to drive innovation and value creation	RE
12-30	Ridgetech Inc on December 29, 2025 co entered into sales agreement with AC SUNSHINE SECURITIES -SEC filing	RE
25-10-29	Ridgetech, Inc. announced that it expects to receive $2.808 million in funding	CI
25-07-28	Ridgetech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-07-28	Ridgetech reports fiscal year 2025 financial results	RE
25-03-03	Ridgetech, Inc. Approves the Appointment of Lingtao Kong as Director	CI
25-02-27	China Jo-Jo Drugstores, Inc. acquired Ridgeline International Limited from Lingtao Kong for CNY 25.65 million.	CI
25-02-02	Li Qi and Lei Liu of China Jo-Jo Drugstore agreed to acquire drug retail business of China Jo-Jo Drugstore from China Jo-Jo Drugstores, Inc. for RM 29.378976 million.	CI
25-02-02	China Jo-Jo Drugstores, Inc. agreed to acquire Allright Internet Technology Co. Ltd.	CI

Ridgetech, Inc. Stock

Stocks

RDGT

KYG2124G2037

Drug Retailers

Valuation: Ridgetech, Inc.

Chart: Ridgetech, Inc.

Latest news: Ridgetech, Inc.

Press Releases: Ridgetech, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Ridgetech, Inc.

Latest insider transactions

Other Drug Retailers

Financials

Company Profile

Quotes

07-24	Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association	PR
04-03	Ridgetech, Inc. Announces 1-for-150 Reverse Share Split	PR
03-04	Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value Creation	PR
25-07-28	Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results	PR
24-04-16	China Jo Jo Drugstores : Report Of Foreign Private Issuer - Form 6-K	PU

1 day	-1.83%
1 week	-10.53%
Current month	-1.81%
1 month	-13.24%
3 months	-44.12%
6 months	-80.57%
Current year	-99.81%

1 week	0.76	1.3
1 month	0.76	1.3
Current year	0.67	702
1 year	0.67	760.5
3 years	0.67	780
5 years	0.67	35,369.84
10 years	0.67	124,559.45

Director	Title	Age	Since
Caroline Wang BRD	Director/Board Member	38	2009-10-02
Geng Hua Gu BRD	Director/Board Member	75	2014-03-27
Jiang Liang He BRD	Director/Board Member	63	2018-09-03

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
7/1/26	HRT Financial LP	Buy	Company	10,197	0.2809%
6/30/26	HRT Financial LP	Other	Company	90,302	2.4880%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
RIDGETECH, INC.	-1.81%	-10.53%	-99.58%	-99.88%	2.99M
JD HEALTH INTERNATIONAL INC.	-0.11%	+0.06%	-45.86%	-11.33%	14.63B
RAIA DROGASIL S.A.	-0.49%	-0.54%	+2.62%	-31.64%	6.2B
TSURUHA HOLDINGS INC.	-0.95%	-3.03%	-11.47%	+4.33%	6.1B
MATSUKIYOCOCOKARA & CO.	+0.51%	-3.18%	-18.49%	-8.66%	6.1B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+1.42%	+1.06%	-56.98%	-41.29%	5.9B
YIFENG PHARMACY CHAIN CO., LTD.	+1.30%	+5.52%	-5.44%	-20.24%	4.21B
NAHDI MEDICAL COMPANY	+0.11%	-0.05%	-23.45%	-36.82%	3.15B
COSMOS PHARMACEUTICAL CORPORATION	+0.94%	-3.50%	-28.11%	-18.78%	3.1B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+2.08%	+1.28%	+10.37%	-27.63%	3.09B
Average	+0.30%	-2.36%	-27.64%	-29.19%	5.25B
Weighted average by Cap.	+0.32%	-1.51%	-25.26%	-18.62%

	2025	2026
Net sales	120M 106M 100M 90.37M 170M 11.5B 173M 1.2B 461M 5.88B 450M 441M 18.85B	132M 116M 110M 99.55M 188M 12.67B 190M 1.32B 508M 6.48B 496M 485M 20.77B
Net income	10.19M 8.98M 8.51M 7.68M 14.47M 977M 14.66M 102M 39.16M 500M 38.28M 37.45M 1.6B	-1.25M -1.1M -1.04M -942K -1.78M -120M -1.8M -12.48M -4.8M -61.29M -4.7M -4.59M -197M
Net Debt	-2.39M -2.11M -1.99M -1.8M -3.39M -229M -3.44M -23.87M -9.19M -117M -8.98M -8.78M -376M	-17.88M -15.75M -14.92M -13.47M -25.39M -1.71B -25.72M -179M -68.7M -877M -67.15M -65.68M -2.81B